An inactivated hepatitis C virus vaccine on the horizon?

Gastroenterology

Volumn 145, Issue 2, 2013, Pages 285-288

  Houghton, Michael ^a   Law, John Lokman ^a   Tyrrell, D Lorne ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

CELLULAR IMMUNITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INACTIVATION;

EID: 84880597479     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.06.029     Document Type: Editorial

References (24)

1. D. Akazawa, M. Moriyama, and H. Yokokawa Neutralizing antibodies induced by cell culture-derived hepatitis c virus protect against infection in mice Gastroenterology 145 2013 447-455
2. WHO fact sheet #164 Hepatitis C 2012 World Health Organization Geneva
3. E. Lawitz, A. Mangia, and D. Wyles Sofosbuvir for previously untreated chronic hepatitis C infection N Engl J Med 368 2013 1878 1887
4. T. Wakita, T. Pietschmann, and T. Kato Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat Med 11 2005 791 796
5. A. Grakoui, N.H. Shoukry, and D.J. Woollard HCV persistence and immune evasion in the absence of memory T cell help Science 302 2003 659 662
6. N.H. Shoukry, A. Grakoui, and M. Houghton Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection J Exp Med 197 2003 1645 1655
7. L. Swadling, P. Klenerman, and E. Barnes Ever closer to a prophylactic vaccine for HCV Expert Opin Biol Ther 2013 May 7 [Epub ahead of print]
8. M. Houghton Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses Immunol Rev 239 2011 99 108
9. J.L. Law, C. Chen, and J. Wong A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans PLoS One 8 2013 e59776
10. S.E. Frey, M. Houghton, and S. Coates Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults Vaccine 28 2010 6367 6373
11. Q.L. Choo, G. Kuo, and R. Ralston Vaccination of chimpanzees against infection by the hepatitis C virus Proc Natl Acad Sci U S A 91 1994 1294 1298
12. M. Law, T. Maruyama, and J. Lewis Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge Nat Med 14 2008 25 27
13. P. Meuleman, J. Bukh, and L. Verhoye In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus Hepatology 53 2011 755 762
14. C. Logvinoff, M.E. Major, and D. Oldach Neutralizing antibody response during acute and chronic hepatitis C virus infection Proc Natl Acad Sci U S A 101 2004 10149 10154
15. D. Lavillette, Y. Morice, and G. Germanidis Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection J Virol 79 2005 6023 6034
16. J.M. Pestka, M.B. Zeisel, and E. Bläser Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C Proc Natl Acad Sci U S A 104 2007 6025 6030
17. T.F. Baumert, S. Wellnitz, and S. Aono Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C Hepatology 32 3 2000 610 617
18. K. Bjøro, S.S. Frøland, and Z. Yun Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin N Engl J Med 331 1994 1607 1611
19. G. Adams, S. Kuntz, and G. Rabalais Natural recovery from acute hepatitis C virus infection by agammaglobulinemic twin children Pediatr Infect Dis J 16 1997 533 534
20. S. Cooper, A.L. Erickson, and E.J. Adams Analysis of a successful immune response against hepatitis C virus Immunity 10 1999 439 449
21. Steenbergen R, Thomas BS, Jones D, et al. Human serum leads to differentiation of a human hepatoma cells, restoration of VLDL secretion, and a 1000-fold increase in HCV JFH-1titers. Hepatology. In press.
22. M. Dorner, J.A. Horwitz, and J.B. Robbins A genetically humanized mouse model for hepatitis C virus infection Nature 474 2011 208 211
23. N.K. Seich Al Basatena, and A. Macnamara KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection PLoS Pathog 7 2011 e1002270
24. D.L. Thomas, C.L. Thio, and M.P. Martin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801